🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆ The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery ◆ GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons ◆ Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing ◆ Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines ◆ Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆ The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery ◆ GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons ◆ Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing ◆ Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines ◆
Updated 21 Aug 2026 · ClinicalTrials.gov

Clinical Trials in Michigan

← All US trials

The most recently updated industry-sponsored clinical trials recruiting across the United States — searchable by condition, sponsor, phase and state. Refreshed daily from the ClinicalTrials.gov registry.

22
Recruiting now
30
Studies tracked
Michigan
Selected state
Recruiting Phase 2
A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis
Atopic Dermatitis
Apogee Therapeutics, Inc. · started 2025-05-14
📍 California · Florida · Georgia · Illinois · Kentucky · Michigan · New York · North Carolina
NCT07003425 on ClinicalTrials.gov ↗
Recruiting Phase 2
A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian Cancer
Ovarian Cancer
AbbVie · started 2025-11-13
📍 California · Florida · Kentucky · Louisiana · Maine · Massachusetts · Michigan · Montana
NCT07059845 on ClinicalTrials.gov ↗
Recruiting Phase 2
A Study of Brenipatide in Adults Who Quit Smoking Cigarettes and Want to Avoid Relapse
Smoking
Eli Lilly and Company · started 2025-11-03
📍 Arkansas · Florida · Georgia · Michigan · Missouri · Nevada · New York · South Carolina
NCT07223840 on ClinicalTrials.gov ↗
Recruiting Phase 1/Phase 2
A Study of ZL-1310 in Participants With Selected Solid Tumors
Solid Tumors
Zai Lab (Shanghai) Co., Ltd. · started 2025-05-12
📍 California · Illinois · Michigan · New York · Ohio · Pennsylvania · Tennessee · Texas
NCT06885281 on ClinicalTrials.gov ↗
Active Phase 2
An Open-label Study of JSB462 (Luxdegalutamide) in Combination With Abiraterone in Adult Male Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
Metastatic Hormone-sensitive Prostate Cancer
Novartis Pharmaceuticals · started 2025-07-07
📍 California · Colorado · Connecticut · Florida · Georgia · Illinois · Massachusetts · Michigan
NCT06991556 on ClinicalTrials.gov ↗
By invitation
Observational Study of VYKAT™ XR in Patients With Prader-Willi Syndrome
Prader-Willi Syndrome
Soleno Therapeutics, Inc. · started 2025-11-26
📍 Arizona · California · Colorado · Georgia · Illinois · Indiana · Massachusetts · Michigan
NCT07450664 on ClinicalTrials.gov ↗
Active Phase 3
A Study of Efficacy and Safety of Ianalumab Versus Placebo in Addition to Eltrombopag in Primary Immune Thrombocytopenia Patients Who Failed Steroids
Primary Immune Thrombocytopenia
Novartis Pharmaceuticals · started 2023-02-02
📍 Arizona · Colorado · Illinois · Massachusetts · Michigan · Montana · New York
NCT05653219 on ClinicalTrials.gov ↗
Recruiting Phase 2
A Study of Intismeran Autogene (V940)/Placebo + Pembrolizumab and Chemotherapy in Metastatic Squamous Non-Small Cell Lung Cancer (V940-013)
Squamous Non-small Cell Lung Cancer
Merck Sharp & Dohme LLC · started 2025-12-12
📍 Florida · Michigan · Missouri · New Jersey · New York · Ohio · Oregon · Tennessee
NCT07221474 on ClinicalTrials.gov ↗
Recruiting Phase 2
A Clinical Study of Calderasib (MK-1084) in People With Advanced Solid Tumors (MK-1084-014)
Neoplasm Malignant
Merck Sharp & Dohme LLC · started 2025-12-04
📍 Maryland · Michigan · Nevada · New Jersey · Utah · Virginia
NCT07209111 on ClinicalTrials.gov ↗
Active Phase 3
A Clinical Trial to Assess the Agent Paclitaxel Coated PTCA Balloon Catheter for the Treatment of Subjects With In-Stent Restenosis (ISR) - Long Lesion Cohort
In-Stent Restenosis
Boston Scientific Corporation · started 2024-10-07
📍 Arizona · California · Georgia · Michigan · New York · Ohio · Pennsylvania · Rhode Island
NCT06492174 on ClinicalTrials.gov ↗
Recruiting Phase 3
Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease
Peripheral Arterial Disease
Eli Lilly and Company · started 2025-10-31
📍 Alabama · Arizona · California · Colorado · Florida · Indiana · Maryland · Michigan
NCT07223593 on ClinicalTrials.gov ↗
Recruiting Phase 3
An Efficacy and Safety Study of Clemizole HCl in Patients With Lennox-Gastaut Syndrome
Lennox Gastaut Syndrome
Epygenix · started 2025-04-09
📍 Arkansas · California · Florida · Illinois · Kentucky · Michigan · Minnesota · Nebraska
NCT05066217 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Study of Eptinezumab in Pediatric Participants With Episodic Migraine
Episodic Migraine
H. Lundbeck A/S · started 2023-06-08
📍 Connecticut · Florida · Georgia · Kentucky · Maryland · Michigan · New York · North Carolina
NCT05897320 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine
Chronic Migraine in Children
H. Lundbeck A/S · started 2021-06-30
📍 Connecticut · District of Columbia · Florida · Georgia · Kentucky · Maryland · Michigan · New York
NCT04965675 on ClinicalTrials.gov ↗
Recruiting Phase 2
A Trial of Lu AG13909 in Adult Participants With Cushing's Disease
Cushing's Disease
H. Lundbeck A/S · started 2024-06-19
📍 Michigan · Missouri
NCT06471829 on ClinicalTrials.gov ↗
Recruiting Phase 2
A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS)
Myelodysplastic Syndromes, Cytopenia
Takeda · started 2020-08-19
📍 Arkansas · California · Florida · Maryland · Michigan · New Jersey · New York · Pennsylvania
NCT04419649 on ClinicalTrials.gov ↗
Recruiting
ADAPT Forward - Master Protocol of a Platform Study to Evaluate the Safety and Efficacy of Multiple Regimens in Participants With Myasthenia Gravis
Myasthenia Gravis, MG, gMG, Generalized Myasthenia Gravis
argenx · started 2025-12-19
📍 California · Florida · Massachusetts · Michigan · New York · North Carolina · Ohio · Tennessee
NCT07294170 on ClinicalTrials.gov ↗
Recruiting Phase 1
A Study of ZL-1310 in Subjects With Small Cell Lung Cancer
SCLC
Zai Lab (Shanghai) Co., Ltd. · started 2024-01-23
📍 California · Connecticut · Florida · Michigan · New Jersey · New York · North Carolina · Ohio
NCT06179069 on ClinicalTrials.gov ↗
Active Phase 3
Safety, Efficacy and Tolerability of Ianalumab Versus Placebo, Combination With SoC Therapy, in Participants With Active Lupus Nephritis
Lupus Nephritis
Novartis Pharmaceuticals · started 2022-07-14
📍 Alabama · California · Florida · Georgia · Louisiana · Michigan · Nevada · New York
NCT05126277 on ClinicalTrials.gov ↗
Recruiting Phase 1/Phase 2
A Clinical Study to Evaluate the Safety and Efficacy of ETX101 in Infants and Children With SCN1A-Positive Dravet Syndrome
Dravet Syndrome
Encoded Therapeutics · started 2024-05-14
📍 California · Colorado · Florida · Illinois · Massachusetts · Michigan · Minnesota · North Carolina
NCT05419492 on ClinicalTrials.gov ↗
By invitation Phase 3
An Extension Study to Learn More About the Long-Term Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus Erythematosus
Systemic Lupus Erythematosus (SLE)
Biogen · started 2022-06-10
📍 Arizona · California · Colorado · District of Columbia · Florida · Georgia · Massachusetts · Michigan
NCT05352919 on ClinicalTrials.gov ↗
Recruiting Phase 2/Phase 3
Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
Heart Failure, Left Ventricular Systolic Dysfunction
Merck Sharp & Dohme LLC · started 2023-05-31
📍 California · Colorado · District of Columbia · Florida · Georgia · Massachusetts · Michigan · Missouri
NCT05714085 on ClinicalTrials.gov ↗
Recruiting Phase 3
Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation
Metastatic Colorectal Cancer
Amgen · started 2024-07-17
📍 Arizona · California · Connecticut · Florida · Georgia · Illinois · Kentucky · Michigan
NCT06252649 on ClinicalTrials.gov ↗
Active Phase 3
Open-label, Long-term Safety Study of Secukinumab in Polymyalgia Rheumatica (PMR)
Polymyalgia Rheumatica
Novartis Pharmaceuticals · started 2024-06-28
📍 Arizona · California · Florida · Maryland · Michigan · New Hampshire · Ohio · Texas
NCT06331312 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Events or Are at High Risk
Atherosclerosis, Cardiovascular Diseases, Lipoprotein(a)
Eli Lilly and Company · started 2026-06-01
📍 California · Florida · Idaho · Massachusetts · Michigan · Nevada · Pennsylvania · Utah
NCT07613294 on ClinicalTrials.gov ↗
Recruiting Phase 1
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
Breast Neoplasms, Colorectal Neoplasms, Prostate Neoplasm, Endometrial Neoplasms
Eli Lilly and Company · started 2025-08-06
📍 California · Florida · Georgia · Massachusetts · Michigan · Missouri · New York · Pennsylvania
NCT07114601 on ClinicalTrials.gov ↗
Recruiting Phase 1
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
Lymphoma, Non-Hodgkin, B-cell Lymphoma, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Follicular
Eli Lilly and Company · started 2026-05-28
📍 California · Colorado · Connecticut · Illinois · Iowa · Kansas · Massachusetts · Michigan
NCT07101328 on ClinicalTrials.gov ↗
Recruiting Phase 3
Phase 3 Trial of VMX-C001 vs Usual Pharmacological Care in Patients Taking a FXa Direct Oral Anticoagulant Who Require Urgent Surgery With or Without Heparin.
Blood Loss, Surgical, Coagulation Disorder
VarmX B.V. · started 2026-08-18
📍 Arizona · California · Colorado · Delaware · Florida · Iowa · Massachusetts · Michigan
NCT07288489 on ClinicalTrials.gov ↗
Active Phase 2
A Phase 2b Study to Evaluate Rezpegaldesleukin (Rezpeg) in the Treatment of Adult Patients With Moderate-to-Severe Atopic Dermatitis
Moderate to Severe Atopic Dermatitis
Nektar Therapeutics · started 2023-11-15
📍 Arkansas · California · Florida · Georgia · Indiana · Kentucky · Michigan · Nevada
NCT06136741 on ClinicalTrials.gov ↗
Recruiting Phase 2
A Study to Evaluate the Efficacy and Safety of Maintenance Ublituximab Following Induction With Efgartigimod Administration in Participants With Myasthenia Gravis (MG)
Myasthenia Gravis
TG Therapeutics, Inc. · started 2026-07-30
📍 Colorado · Florida · Michigan · North Carolina
NCT07673744 on ClinicalTrials.gov ↗
No trials match your search.

Browse by state

California · 112 Florida · 111 Georgia · 60 Colorado · 54 Arizona · 53 Illinois · 48 New York · 44 Massachusetts · 41 Connecticut · 38 Alabama · 37 Michigan · 30 Indiana · 27 Maryland · 27 Ohio · 26 Arkansas · 23 Kentucky · 21

Browse by condition

Prostate Cancer · 5 Ovarian Cancer · 4 Overweight · 4 Obesity · 4 Systemic Lupus Erythematosus · 3 Ulcerative Colitis · 3 Follicular Lymphoma · 3 Heart Failure · 3 Non-small Cell Lung Cancer · 3 Lymphoma, Large B-Cell, Diffuse · 2 Diabetes Mellitus, Type 1 · 2 Breast Neoplasms · 2 B-cell Malignancy · 2 Hidradenitis Suppurativa · 2 Acute Myeloid Leukemia · 2 Ovarian Neoplasms · 2
Cite this page

Priya Life Science (2026). Clinical Trials in the USA Tracker. Available at: https://priyalifescience.com/clinical-trials-usa/state/michigan (Accessed: 22 August 2026).

Embed this data ↗

Source: ClinicalTrials.gov, U.S. National Library of Medicine — industry-sponsored studies in a recruiting status with at least one US site, most recently updated first, refreshed daily. This is a curated slice of the full registry, not every US trial. Listing here is informational and not medical advice; eligibility is determined by each study team. Patients should discuss participation with their clinician. Compare pay for the teams running these studies in our US Pharma Salary Guide, see who's behind them in the US Company Directory, or track approvals on the FDA Approvals Tracker. For Irish and EU sites, see our Ireland and EU trackers.